U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Tobacco Products
  3. Tobacco Science & Research
  4. Research
  5. Funding Opportunities
  1. Research

Funding Opportunities

CTP's Scientific Conference Grant Program Priorities 

Through a trans-HHS collaborative research effort between the Institutes and Centers of the National Institutes of Health (NIH) and the Food and Drug Administration’s (FDA) Center for Tobacco Products (CTP), the Tobacco Regulatory Science Program (TRSP) offers research funding opportunities focused on tobacco regulatory science. CTP also partners with other parts of the FDA to participate in agency-wide funding opportunities to advance the field of tobacco regulatory science.

Current Funding Opportunities

  1. FY25 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science (FDABAA-25-00123)

    FDA solicits and funds extramural research through an agency-wide Broad Agency Announcement (BAA) for advanced research and development proposals to support regulatory science and innovation. CTP participates in the BAA solicitation, and tobacco priority topics are included in sections I.C.13.a. More on application details can be found in the contract solicitation. 
    Stage One Submittal Packages (Concept Paper and Full Proposal) for FY25 funding consideration due date: February 24, 2024.
     
  2. High-Priority Research in Tobacco Regulatory Science (R01 Clinical Trial Optional) RFA-OD-25-001

    The purpose of this Notice of Funding Opportunity (NOFO) is to invite R01 applications to support new high-priority biomedical and behavioral research that will provide scientific data to inform the regulation of tobacco products to protect public health. Research Projects must address the new high-priority research topics related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP). The awards under this NOFO will be administered by NIH using funds that have been made available through FDA CTP and the Family Smoking Prevention and Tobacco Control Act (FSPTCA), P.L. 111-31. Research results from this NOFO are expected to generate findings and data that are directly relevant in informing the FDA's regulation of the manufacture, distribution, and marketing of tobacco products to protect public health. 
    Application due date: June 06, 2025.
     
  3. FDA Support for Conferences and Scientific Meetings (R13)

    The purpose of the FDA (R13) Scientific Conference Grant Program is to facilitate the provision of federal financial assistance in support of high-quality conferences and scientific meetings designed to research and investigate a topic clearly aligned with the FDA mission. The FDA recognizes the value of supporting high quality conferences and scientific meetings relevant to its mission and to the public health. A conference or scientific meeting is defined as a symposium, seminar, workshop, or any formal meeting, whether conducted face-to-face or virtually to exchange information and explore a defined subject, issue, or area of concern impacting the public's health within the scope of the FDA's mission.
    Application due dates: April 12, 2023; October 12, 2023; April 12, 2024; October 11, 2024; April 11, 2025; and October 10, 2025 by 11:59 p.m. EST.

In addition to supporting research through NIH's programs, CTP solicits proposals for research contracts administered by FDA. Those opportunities are published through the Federal Business Opportunities website and also posted on the CTP website.

Additional Resources

Back to Top